United States Ankylosing Spondylitis Drugs Market Report 2017

January 2017 | 104 pages | ID: UF8EA8C0595EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Ankylosing Spondylitis Drugs

Revenue, means the sales value of Ankylosing Spondylitis Drugs

This report studies sales (consumption) of Ankylosing Spondylitis Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Abbvie
• Amgen
• Janssen Biotech, Inc.
• Merck & Co.
• UCB
• Boehringer Ingelheim
• Johnson & Johnson

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Nonsteroidal anti-inflammatory drugs (NSAIDs)
• TNF blockers and IL-17 inhibitors
• Other

Split by applications, this report focuses on sales, market share and growth rate of Ankylosing Spondylitis Drugs in each application, can be divided into

• Juveniles
• Adults

Contents

United States Ankylosing Spondylitis Drugs Market Report 2017

1 ANKYLOSING SPONDYLITIS DRUGS OVERVIEW

1.1 Product Overview and Scope of Ankylosing Spondylitis Drugs
1.2 Classification of Ankylosing Spondylitis Drugs
  1.2.1 Nonsteroidal anti-inflammatory drugs (NSAIDs)
  1.2.2 TNF blockers and IL-17 inhibitors
  1.2.3 Other
1.3 Application of Ankylosing Spondylitis Drugs
  1.3.1 Juveniles
  1.3.2 Adults
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Ankylosing Spondylitis Drugs (2011-2021)
  1.4.1 United States Ankylosing Spondylitis Drugs Sales and Growth Rate (2011-2021)
  1.4.2 United States Ankylosing Spondylitis Drugs Revenue and Growth Rate (2011-2021)

2 UNITED STATES ANKYLOSING SPONDYLITIS DRUGS COMPETITION BY MANUFACTURERS

2.1 United States Ankylosing Spondylitis Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Ankylosing Spondylitis Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Ankylosing Spondylitis Drugs Average Price by Manufactures (2015 and 2016)
2.4 Ankylosing Spondylitis Drugs Market Competitive Situation and Trends
  2.4.1 Ankylosing Spondylitis Drugs Market Concentration Rate
  2.4.2 Ankylosing Spondylitis Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES ANKYLOSING SPONDYLITIS DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)

3.1 United States Ankylosing Spondylitis Drugs Sales and Market Share by States (2011-2016)
3.2 United States Ankylosing Spondylitis Drugs Revenue and Market Share by States (2011-2016)
3.3 United States Ankylosing Spondylitis Drugs Price by States (2011-2016)

4 UNITED STATES ANKYLOSING SPONDYLITIS DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

4.1 United States Ankylosing Spondylitis Drugs Sales and Market Share by Type (2011-2016)
4.2 United States Ankylosing Spondylitis Drugs Revenue and Market Share by Type (2011-2016)
4.3 United States Ankylosing Spondylitis Drugs Price by Type (2011-2016)
4.4 United States Ankylosing Spondylitis Drugs Sales Growth Rate by Type (2011-2016)

5 UNITED STATES ANKYLOSING SPONDYLITIS DRUGS SALES (VOLUME) BY APPLICATION (2011-2016)

5.1 United States Ankylosing Spondylitis Drugs Sales and Market Share by Application (2011-2016)
5.2 United States Ankylosing Spondylitis Drugs Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 UNITED STATES ANKYLOSING SPONDYLITIS DRUGS MANUFACTURERS PROFILES/ANALYSIS

6.1 Abbvie
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Ankylosing Spondylitis Drugs Product Type, Application and Specification
    6.1.2.1 Nonsteroidal anti-inflammatory drugs (NSAIDs)
    6.1.2.2 TNF blockers and IL-17 inhibitors
  6.1.3 Abbvie Ankylosing Spondylitis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.1.4 Main Business/Business Overview
6.2 Amgen
  6.2.2 Ankylosing Spondylitis Drugs Product Type, Application and Specification
    6.2.2.1 Nonsteroidal anti-inflammatory drugs (NSAIDs)
    6.2.2.2 TNF blockers and IL-17 inhibitors
  6.2.3 Amgen Ankylosing Spondylitis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.2.4 Main Business/Business Overview
6.3 Janssen Biotech, Inc.
  6.3.2 Ankylosing Spondylitis Drugs Product Type, Application and Specification
    6.3.2.1 Nonsteroidal anti-inflammatory drugs (NSAIDs)
    6.3.2.2 TNF blockers and IL-17 inhibitors
  6.3.3 Janssen Biotech, Inc. Ankylosing Spondylitis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.3.4 Main Business/Business Overview
6.4 Merck & Co.
  6.4.2 Ankylosing Spondylitis Drugs Product Type, Application and Specification
    6.4.2.1 Nonsteroidal anti-inflammatory drugs (NSAIDs)
    6.4.2.2 TNF blockers and IL-17 inhibitors
  6.4.3 Merck & Co. Ankylosing Spondylitis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.4.4 Main Business/Business Overview
6.5 UCB
  6.5.2 Ankylosing Spondylitis Drugs Product Type, Application and Specification
    6.5.2.1 Nonsteroidal anti-inflammatory drugs (NSAIDs)
    6.5.2.2 TNF blockers and IL-17 inhibitors
  6.5.3 UCB Ankylosing Spondylitis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.5.4 Main Business/Business Overview
6.6 Boehringer Ingelheim
  6.6.2 Ankylosing Spondylitis Drugs Product Type, Application and Specification
    6.6.2.1 Nonsteroidal anti-inflammatory drugs (NSAIDs)
    6.6.2.2 TNF blockers and IL-17 inhibitors
  6.6.3 Boehringer Ingelheim Ankylosing Spondylitis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.6.4 Main Business/Business Overview
6.7 Johnson & Johnson
  6.7.2 Ankylosing Spondylitis Drugs Product Type, Application and Specification
    6.7.2.1 Nonsteroidal anti-inflammatory drugs (NSAIDs)
    6.7.2.2 TNF blockers and IL-17 inhibitors
  6.7.3 Johnson & Johnson Ankylosing Spondylitis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.7.4 Main Business/Business Overview

7 ANKYLOSING SPONDYLITIS DRUGS MANUFACTURING COST ANALYSIS

7.1 Ankylosing Spondylitis Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Ankylosing Spondylitis Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Ankylosing Spondylitis Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Ankylosing Spondylitis Drugs Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ANKYLOSING SPONDYLITIS DRUGS MARKET FORECAST (2016-2021)

11.1 United States Ankylosing Spondylitis Drugs Sales, Revenue Forecast (2016-2021)
11.2 United States Ankylosing Spondylitis Drugs Sales Forecast by Type (2016-2021)
11.3 United States Ankylosing Spondylitis Drugs Sales Forecast by Application (2016-2021)
11.4 Ankylosing Spondylitis Drugs Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Ankylosing Spondylitis Drugs
Table Classification of Ankylosing Spondylitis Drugs
Figure United States Sales Market Share of Ankylosing Spondylitis Drugs by Type in 2015
Figure Nonsteroidal anti-inflammatory drugs (NSAIDs) Picture
Figure TNF blockers and IL-17 inhibitors Picture
Figure Other Picture
Table Application of Ankylosing Spondylitis Drugs
Figure United States Sales Market Share of Ankylosing Spondylitis Drugs by Application in 2015
Figure Juveniles Examples
Figure Adults Examples
Figure United States Ankylosing Spondylitis Drugs Sales and Growth Rate (2011-2021)
Figure United States Ankylosing Spondylitis Drugs Revenue and Growth Rate (2011-2021)
Table United States Ankylosing Spondylitis Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Ankylosing Spondylitis Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Ankylosing Spondylitis Drugs Sales Share by Manufacturers
Figure 2016 Ankylosing Spondylitis Drugs Sales Share by Manufacturers
Table United States Ankylosing Spondylitis Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Ankylosing Spondylitis Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Ankylosing Spondylitis Drugs Revenue Share by Manufacturers
Table 2016 United States Ankylosing Spondylitis Drugs Revenue Share by Manufacturers
Table United States Market Ankylosing Spondylitis Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Ankylosing Spondylitis Drugs Average Price of Key Manufacturers in 2015
Figure Ankylosing Spondylitis Drugs Market Share of Top 3 Manufacturers
Figure Ankylosing Spondylitis Drugs Market Share of Top 5 Manufacturers
Table United States Ankylosing Spondylitis Drugs Sales by States (2011-2016)
Table United States Ankylosing Spondylitis Drugs Sales Share by States (2011-2016)
Figure United States Ankylosing Spondylitis Drugs Sales Market Share by States in 2015
Table United States Ankylosing Spondylitis Drugs Revenue and Market Share by States (2011-2016)
Table United States Ankylosing Spondylitis Drugs Revenue Share by States (2011-2016)
Figure Revenue Market Share of Ankylosing Spondylitis Drugs by States (2011-2016)
Table United States Ankylosing Spondylitis Drugs Price by States (2011-2016)
Table United States Ankylosing Spondylitis Drugs Sales by Type (2011-2016)
Table United States Ankylosing Spondylitis Drugs Sales Share by Type (2011-2016)
Figure United States Ankylosing Spondylitis Drugs Sales Market Share by Type in 2015
Table United States Ankylosing Spondylitis Drugs Revenue and Market Share by Type (2011-2016)
Table United States Ankylosing Spondylitis Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Ankylosing Spondylitis Drugs by Type (2011-2016)
Table United States Ankylosing Spondylitis Drugs Price by Type (2011-2016)
Figure United States Ankylosing Spondylitis Drugs Sales Growth Rate by Type (2011-2016)
Table United States Ankylosing Spondylitis Drugs Sales by Application (2011-2016)
Table United States Ankylosing Spondylitis Drugs Sales Market Share by Application (2011-2016)
Figure United States Ankylosing Spondylitis Drugs Sales Market Share by Application in 2015
Table United States Ankylosing Spondylitis Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Ankylosing Spondylitis Drugs Sales Growth Rate by Application (2011-2016)
Table Abbvie Basic Information List
Table Abbvie Ankylosing Spondylitis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbvie Ankylosing Spondylitis Drugs Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Ankylosing Spondylitis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Ankylosing Spondylitis Drugs Sales Market Share (2011-2016)
Table Janssen Biotech, Inc. Basic Information List
Table Janssen Biotech, Inc. Ankylosing Spondylitis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Janssen Biotech, Inc. Ankylosing Spondylitis Drugs Sales Market Share (2011-2016)
Table Merck & Co. Basic Information List
Table Merck & Co. Ankylosing Spondylitis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck & Co. Ankylosing Spondylitis Drugs Sales Market Share (2011-2016)
Table UCB Basic Information List
Table UCB Ankylosing Spondylitis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table UCB Ankylosing Spondylitis Drugs Sales Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Ankylosing Spondylitis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim Ankylosing Spondylitis Drugs Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Ankylosing Spondylitis Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Ankylosing Spondylitis Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ankylosing Spondylitis Drugs
Figure Manufacturing Process Analysis of Ankylosing Spondylitis Drugs
Figure Ankylosing Spondylitis Drugs Industrial Chain Analysis
Table Raw Materials Sources of Ankylosing Spondylitis Drugs Major Manufacturers in 2015
Table Major Buyers of Ankylosing Spondylitis Drugs
Table Distributors/Traders List
Figure United States Ankylosing Spondylitis Drugs Production and Growth Rate Forecast (2016-2021)
Figure United States Ankylosing Spondylitis Drugs Revenue and Growth Rate Forecast (2016-2021)
Table United States Ankylosing Spondylitis Drugs Production Forecast by Type (2016-2021)
Table United States Ankylosing Spondylitis Drugs Consumption Forecast by Application (2016-2021)
Table United States Ankylosing Spondylitis Drugs Sales Forecast by States (2016-2021)
Table United States Ankylosing Spondylitis Drugs Sales Share Forecast by States (2016-2021)